Suven Life Sciences P/B Ratio

Current P/B Ratio
11.86
High Valuation
Very High - Significant premium, high growth expectations or speculative

Suven Life Sciences (SUVEN) P/B ratio is 11.86 (High), book value per share ₹227.31 vs Healthcare average P/B of -0.33 — Very High - Significant premium, high growth expectations or speculative. View SUVEN yearly price range for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 11.86
Current Price ₹267.15
Book Value/Share ₹227.31
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹591 Cr
Share Capital ₹26 Cr
Reserves & Surplus ₹565 Cr
Outstanding Shares 26,000,000
Book Value per Share ₹227.31

Valuation Signal

Signal Overvalued
Historical Avg 1.42
Historical Range 0.47 - 3.33
Percentile 100.0%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

SUVEN P/B Ratio — Valuation Insights & Book Value Analysis

Suven Life Sciences price-to-book ratio interpretation, valuation status and historical context — current P/B 11.86 (High). Compare with Suven Life Sciences value estimation to assess whether the stock is under or overvalued.

  • Stock appears overvalued with PB of 11.86, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 736.4% above historical average
  • Trading at premium to sector average PB of -0.33

Suven Life Sciences P/B Ratio Historical Trend

SUVEN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Suven Life Sciences stock price NSE.

SUVEN Historical P/B Ratio — Book Value Per Share & Year-End Price

Suven Life Sciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 1.18 ₹227.31 ₹267.15 ₹591 Moderate
2025 3.33 ₹50.0 ₹166.27 ₹110 High
2024 1.04 ₹122.73 ₹128.00 ₹270 Moderate
2023 0.47 ₹170.45 ₹80.66 ₹375 Low
2022 1.07 ₹64.0 ₹68.50 ₹96 Moderate

SUVEN vs Healthcare Peers — P/B Ratio Comparison

Suven Life Sciences P/B 11.86 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low